News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
27 Nov 2024
byStephen Padilla
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis who are taking antihypertensive medications, including calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), are at increased risk of developing hepatocellular carcinoma (HCC), suggests a study.
27 Nov 2024

Alcoholic drinks up risk of death in young adults with MASLD
26 Nov 2024
byStephen Padilla
Young adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink alcoholic beverages are at greater risk of mortality and of having an unhealthy liver, reports a study presented at AASLD 2024.
26 Nov 2024







